Simple Urine Composition-based Personalized Algorithm for Effective Congestion Relief in Decompensated Heart Failure

Recruiting N/A Interventional Study
Acute Heart Failure (AHF) Congestion, Venous
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
90 (estimated)
Sponsor
Wroclaw Medical University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The aim of this study is to evaluate the effectiveness of loop diuretic adaptative algorithm that is based on machine learning, urine output prediction tool, in decongestion of acute heart failure patients. A total of 90 patients will be enrolled in the study. Of these, 45 will be assigned to the algorithm-based intervention group, while the remaining 45 will serve as the control group. In the co…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult patients over 18 years of age who provide informed consent * Ability to enroll in the study within the first 24 hours of hospitalization * Primary reason for hospitalization is acute heart failure with signs of congestion (at least moderate lower extremity edema) * NT-pr…
Contacts

Jan Biegus, MD, PhD

71 736 42 05

jan.biegus@umw.edu.pl

CONTACT

Gracjan Iwanek, MD

71 733 11 12

gracjan.iwanek@student.umw.edu.pl

CONTACT